CAM
BCAB icon

Cormorant Asset Management’s BioAtla BCAB Stock Holding History

Cormorant Asset Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,417
Closed -$4.03M – 55
2024
Q1 		$4.03M Sell
23,417
-205
-0.9% -$25.5K 0.18% 57
2023
Q4 		$2.91M Hold
23,622
– – 0.14% 47
2023
Q3 		$2.01M Hold
23,622
– – 0.12% 45
2023
Q2 		$3.54M Hold
23,622
– – 0.2% 53
2023
Q1 		$3.17M Sell
23,622
-49,985
-68% -$9M 0.21% 54
2022
Q4 		$30.4M Buy
73,607
+29,985
+69% +$12.4M 2.03% 14
2022
Q3 		$16.8M Buy
43,622
+2,858
+7% +$936K 1.17% 30
2022
Q2 		$5.81M Hold
40,764
– – 0.44% 49
2022
Q1 		$10.2M Buy
40,764
+7,142
+21% +$2.99M 0.78% 40
2021
Q4 		$33M Sell
33,622
-2,689
-7% -$3.44M 1.96% 14
2021
Q3 		$53.5M Sell
36,311
-2,723
-7% -$5.3M 2.17% 13
2021
Q2 		$82.7M Sell
39,034
-4,807
-11% -$10.9M 2.81% 9
2021
Q1 		$110M Sell
43,841
-2,000
-4% -$5.13M 2.45% 10
2020
Q4 		$75.4M Buy
+45,841
New +$76.6M 1.79% 17

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Cormorant Asset Management's BCAB Position: Q2 2024 in Review

Cormorant Asset Management sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 23,417 shares — an estimated $4.03M sold.

Cormorant Asset Management first reported a position in BCAB in Q4 2020 and held it in 14 quarters. The position peaked at $110M in Q1 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • Cormorant Asset Management reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • Cormorant Asset Management sold 23,417 BioAtla shares in Q2 2024, an estimated $4.03M.
  • Cormorant Asset Management first reported a position in BioAtla in Q4 2020 and held it in 14 quarters.
  • Cormorant Asset Management's BioAtla position peaked at $110M in Q1 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Cormorant Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.